Ribomic Inc.

2026/07/24 Updated
Market Cap: $25.3M (¥4.1B)
Stock Price: $0.45 (¥74)
Exchange Rate: 1 USD = ¥163.67

Notice of Public Disclosure of JRCT Registration Information for Domestic Phase III Clinical Trial of Growth Hormone-Deficient Osteogenesis/Osteochondral Hypoplasia Treatment (umedaptanib pegol)

Importance:
Page Updated: July 8, 2026
IR Disclosure Date: July 8, 2026
その他

G-リボミック

Company overview · Stock price · Financial data · All IR

View company page →